Non-ownership Filings
| AstraZeneca prices a $2bn bond offering | Feb. 26, 2026 |
| Filing of Form 20-F with SEC | Feb. 25, 2026 |
| Annual Financial Report | Feb. 24, 2026 |
| Directorate change | Feb. 24, 2026 |
| Fixed-duration Calquence combo approved in US | Feb. 20, 2026 |
| Final Results | Feb. 10, 2026 |
| Update on Saphnelo subcutaneous administration | Feb. 03, 2026 |
Ownership Update Filings
| Director/PDMR Shareholding | Dec. 22, 2025 |
| Director/PDMR Shareholding | Dec. 19, 2025 |
| Director/PDMR Shareholding | Nov. 14, 2025 |
| Director/PDMR Shareholding | Nov. 10, 2025 |
| Director/PDMR Shareholding | Sep. 25, 2025 |
| Holding(s) in Company | Aug. 28, 2025 |
| Holding(s) in Company | Aug. 26, 2025 |